 | Study programme 2021-2022 | Français | |
 | Formes pharmaceutiques innovantes | ||
Programme component of Master's in Pharmacy à la Faculty of Medicine and Pharmacy |
| Code | Type | Head of UE | Department’s contact details | Teacher(s) |
|---|---|---|---|---|
| UM-M2-PHARMA-023-M | Optional UE | VANDERBIST Francis | M111 - Pharmacie Galénique |
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Credits | Weighting | Term |
|---|---|---|---|---|---|---|---|---|---|
| Français | 10 | 0 | 0 | 0 | 0 | 1 | 1.00 | 1st term |
| AA Code | Teaching Activity (AA) | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term | Weighting |
|---|---|---|---|---|---|---|---|---|
| M-DOYM-227 | Formes pharmaceutiques innovantes | 10 | 0 | 0 | 0 | 0 | Q1 | 100.00% |
| Programme component |
|---|
Objectives of Programme's Learning Outcomes
Learning Outcomes of UE
COURS A OPTIONS - Francis Vanderbist- MA2- Pharmacy
Année académique 2021-2022
Content of the UE - Innovative pharmaceutical Formulations (10h)
This specific lesson consists in the presentation, description and explanation of specific and innovative new pharmaceutical forms.
The lesson is mainly about recent pharmaceutical compositions for which an intensively research is undertaken for various pharmaceutical applications.
The compositions are generally already in clinical trials but are not yet be submitted for any regulatory approval. Nevertheless, these formulations should become available for patients in short to mid-term.
Content of UE
Content of the UE - Innovative pharmaceutical Formulations (10h)
This specific lesson consists in the presentation, description and explanation of specific and innovative new pharmaceutical forms.
The lesson is mainly about recent pharmaceutical compositions for which an intensively research is undertaken for various pharmaceutical applications.
The compositions are generally already in clinical trials but are not yet be submitted for any regulatory approval. Nevertheless, these formulations should become available for patients in short to mid-term.
Prior Experience
Good knowledge of galenics and Pharmaceutical Technology : MA1-Q1 (088) and MA1-Q2 (089)
Type of Assessment for UE in Q1
- Presentation and/or works
Q1 UE Assessment Comments
Student's Powerpoint presentation + questions and answers part
Type of Assessment for UE in Q3
- Presentation and/or works
Q3 UE Assessment Comments
Student's Powerpoint presentation + questions and answers part
Type of Resit Assessment for UE in Q1 (BAB1)
- N/A
Q1 UE Resit Assessment Comments (BAB1)
not-applicable
Type of Teaching Activity/Activities
| AA | Type of Teaching Activity/Activities |
|---|---|
| M-DOYM-227 |
|
Mode of delivery
| AA | Mode of delivery |
|---|---|
| M-DOYM-227 |
|
Required Reading
| AA | |
|---|---|
| M-DOYM-227 |
Required Learning Resources/Tools
| AA | Required Learning Resources/Tools |
|---|---|
| M-DOYM-227 | slides put on Moodle platform |
Recommended Reading
| AA | |
|---|---|
| M-DOYM-227 |
Recommended Learning Resources/Tools
| AA | Recommended Learning Resources/Tools |
|---|---|
| M-DOYM-227 | Bibliographical references |
Other Recommended Reading
| AA | Other Recommended Reading |
|---|---|
| M-DOYM-227 | Not applicable |
Grade Deferrals of AAs from one year to the next
| AA | Grade Deferrals of AAs from one year to the next |
|---|---|
| M-DOYM-227 | Authorized |